COAGULATION FACTOR-X INHIBITOR FROM HUNDRED-PACE SNAKE (DEINAGKISTRODON-ACUTUS) VENOM

Deinagkistrodon acutus venom contains a collection of anticoagulant proteins that has been reported to prevent prothrombinase assembly (TENG and SEEGERs, 1981, Thromb. Res. 23, 255). A partial sequence indicates that these proteins are related to the functionally equivalent protein in Trimeresurus flavoviridis (ATODA et al., 1991, J. Biochem. 106, 808). Inhibition of prothrombinase, the complex of Factors X(a) and V(a) combined with phospholipids, is expressed in bovine, human, and rat plasmas as indicated by an assay dependent on only prothrombinase activity. The concentration dependence of inhibition of prothrombin conversion by different combinations of the components of bovine prothrombinase under the same conditions yielded estimates of apparent dissociation constants of 104 nM and 2 nM for complexes of the inhibitor with Factor X(a) and with Factors X(a) and V(a), respectively. Because this inhibitor does not prevent Factor X(a) alone from converting prothrombin, but blocks the other combinations, we conclude the inhibitor prevents the complex of Factors X(a) and V(a) from binding to phospholipid surfaces and to prothrombin. The inhibitor also blocks the activation of Factor X by Factor VII(a) and thromboplastin as well. However, the inhibitor has no effect on thrombin-induced clotting or fibrinolysis induced by either plasminogen activator or streptokinase. Therefore, this inhibitor has several properties required of an anticoagulant, therapeutic agent.